Infinitus Takes Part in a Symposium Advocating High-Quality Development with Integrity and Compliance

GUANGZHOU, China, June 21, 2023 /PRNewswire/ — China Market Regulation News organized a symposium in Beijing on June 16 to discuss the implementation the government’s recently issued outline for enhancing the overall quality of the economy amid efforts to promote high-quality development. The symposium convened market regulatory bodies, industry organizations, economic experts, and representatives from the private sector at all levels. Infinitus (China) Company Ltd. (“Infinitus”), as the sole representative from its industry, actively participated in the guest exchange and roundtable discussion, aiming to gain insights into the practical implementation of the guidelines and engage in the dialog on integrity, compliance and high-quality development.

According to Zhang Xia, President of China Market Regulation News, speaking on behalf of the event organizer, the symposium aimed to foster effective implementation of the guidelines by inviting representatives from government authorities, industry associations and, most importantly, the private sector. Emphasizing the significance of integrity and compliance, Zhang highlighted that businesses’ adherence to these principles enables them to establish favorable reputations, gain a competitive edge, and mitigate risks and costs. By doing so, businesses can strive towards achieving high-quality and sustainable development.


Infinitus (China) Company Ltd. CEO Huang Jianlong delivering a keynote speech

Huang Jianlong, CEO of Infinitus (China) Company Ltd., delivered a keynote speech on the theme of “Implementing the First Responsibility for Quality and Safety, Providing Safe and Trusted Consumer Goods.” He emphasized that quality and safety are, at the national level, “absolute musts” inextricably linked to economic development and social cohesion. He further highlighted their significance to consumers as they impact everyone’s life and well-being. For Infinitus, quality and safety serve as the ultimate arbiters, determining the prosperity or failure of their businesses. For more than 30 years, Infinitus has adhered to the quality principle of “100-1=0”, reflecting their unwavering commitment to perfection. The company has implemented comprehensive quality control measures throughout the entire product lifecycle, including development, cultivation, production, sales, testing, logistics and after-sales service, all aimed at ensuring the highest standards of product quality and safety.

The symposium concluded with the introduction of a collaborative initiative aimed at promoting high-quality development through integrity and compliance. Infinitus actively engaged in the project, aspiring to foster quality awareness as an intrinsic driving force, while diligently fulfilling its significant responsibilities. Multiple business leaders from Infinitus jointly launched the initiative, urging collective efforts to establish an environment of honesty and compliance within the market and to bolster the sector’s growth in terms of quality.

The significant event coincided with Infinitus Norm Management Day, underscoring the company’s notable recognition and approval from regulatory bodies. Infinitus remains committed to fulfilling its corporate social responsibilities, upholding standards and self-discipline, and collaborating with others to cultivate an ethical business environment. Additionally, the company is dedicated to aligning with the national development strategy and making substantial contributions to the high-quality development of the industry.

 

Subscribe on LinkedIn

Get the free newsletter

Subscribe to MedicaEx for top news, trends & analysis

We're committed to your privacy. MedicaEx uses the information you provide to us to contact you about our relevant content, products, and services. You may unsubscribe from these communications at any time. For more information, check out our Privacy Policy.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

PR Newswire is solely responsible for the content of the above news submissions. If there are any violations of laws, violations of the membership terms of this website, or the risk of infringing on the rights of third parties, PR Newswire will be solely responsible for legal and damage compensation. Responsibility has nothing to do with MedicaEx.

Are you in?

Subscribe to receive exclusive content and notifications to your inbox

We're committed to your privacy. MedicaEx uses the information you provide to us to contact you about our relevant content, products, and services. You may unsubscribe from these communications at any time. For more information, check out our Privacy Policy.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.